
Company valuation, historical trends, and peer comparisons.
According to Spruce Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 43.73M. This represents a change of 75.45% compared to the average of 24.92M of the last 4 quarters.
The mean historical Enterprise Value of Spruce Biosciences, Inc. over the last ten years is 241.07M. The current 43.73M Enterprise Value has changed -81.86% with respect to the historical average. Over the past ten years (40 quarters), SPRB's Enterprise Value was at its highest in in the December 2020 quarter at 950.78M. The Enterprise Value was at its lowest in in the June 2024 quarter at -44677090.74.
Average
241.07M
Median
26.69M
Minimum
-19090014.00
Maximum
951.87M
Discovering the peaks and valleys of Spruce Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.38%
Maximum Annual Enterprise Value = 951.87M
Minimum Annual Increase = -204.41%
Minimum Annual Enterprise Value = -19090014.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 18.61M | -197.48% |
| 2024 | -19090014.00 | -204.41% |
| 2023 | 18.28M | -43.14% |
| 2022 | 32.16M | -80.74% |
| 2021 | 166.96M | -82.46% |
| 2020 | 951.87M | 28.88% |
| 2019 | 738.56M | 3.38% |
The current Enterprise Value of Spruce Biosciences, Inc. (SPRB) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
5.93M
5-year avg
43.38M
10-year avg
241.07M
Spruce Biosciences, Inc.’s Enterprise Value is less than NRx Pharmaceuticals, Inc. (70.89M), greater than Werewolf Therapeutics, Inc. (27.10M), less than Outlook Therapeutics, Inc. (122.46M), greater than IO Biotech, Inc. (-28323310.00), less than Cue Biopharma, Inc. (140.63M), less than OS Therapies Incorporated (57.25M), greater than vTv Therapeutics Inc. (11.16M), greater than Equillium, Inc. (30.29M), less than Coeptis Therapeutics Holdings, Inc. (178.43M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 70.89M | $96.33M | |
| 27.10M | $49.09M | |
| 122.46M | $115.27M | |
| -28323310.00 | $885.69K | |
| 140.63M | $149.21M | |
| 57.25M | $57.46M | |
| 11.16M | $97.80M | |
| 30.29M | $86.87M | |
| 178.43M | $38.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spruce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Spruce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Spruce Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Spruce Biosciences, Inc. (SPRB)?
What is the 3-year average Enterprise Value for Spruce Biosciences, Inc. (SPRB)?
What is the 5-year average Enterprise Value for Spruce Biosciences, Inc. (SPRB)?
How does the current Enterprise Value for Spruce Biosciences, Inc. (SPRB) compare to its historical average?